window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-113618785-7');
Loading...
Home2020-06-22T16:16:14+00:00

AutoCRAT is a Horizon 2020 Project focused on:

  • delivering new cell and cell-based therapies for osteoarthritis (OA) and joint repair using sustainable sources of cells and

  • developing a closed, scalable and regulatory-compliant automated system to enable future production of therapeutic products.

Repairing Damage

Repairing Damage

AutoCRAT will explore using articular chondrocytes (cartilage cells) to help repair damage to joints.

Preventing & Treating OA

Preventing & Treating OA

AutoCRAT will explore using mesenchymal stromal cells (MSC) and extracellular vesicles (EVs) to prevent and to treat OA.

Generating Cells

Generating Cells

AutoCRAT will generate sustainable sources of cells ready for therapeutic use.

Automated Production

Automated Production

AutoCRAT will build a Regenerative Medicine Factory for cost-effective, controlled, automated manufacture of therapeutic products in line with regulations.

Find out more about the Project

The AutoCRAT Team

The AutoCRAT consortium is made up of the following partners:

Find out more about the Team here.

Latest News

Read all about our news, project updates and announcements on our news page.

Prof Simonsson, U of Gothenburg invites abstracts and chairs iPSC symposium at TERMIS 2021

July 30th, 2020|

The much-anticipated 6th TERMIS meeting is slated for May 31- June 4th, 2021. The meeting will take place in Maastricht in the Netherlands. AutoCRAT PI Prof Stina Simonsson of the University of Gothenburg will chair [...]

Read more
Go to Top